Business profile

Cardioderma Oy

Cardioderma Oy's registered office is Karleby. It is a limited company. The company was established on 2012-11-23. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-04-30, revenue was €255,487 and operating profit was €117,106.

Claim profileContact details
Business ID 2512010-5ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
2512010-5
Sector
Medical specialists activities
Municipality
Karleby
Company form
Limited company
Registration date
2012-11-23
Business ID registration date
2012-11-16
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Oksatie 1, 67400, Karleby

About Cardioderma Oy

Financial position and key figures for the company.

Cardioderma Oy's location municipality is Karleby. It is a limited company. The company was established on 2012-11-23. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-04-30, revenue was €255,487 and operating profit was €117,106. The latest retained financial statement for 2025-04-30 shows revenue of €255,487 and profit for the financial year of €93,520. Based on the latest retained statement, revenue growth was +7.6%, operating margin was +45.8%, and equity ratio was +97.8%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-04-30

Imported periods4
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth7.6%
Operating margin45.8%
Equity ratio97.8%
Revenue€255,487+€18,018 (+7.6%) vs previous periodPrevious: €237,469
Operating profit (loss)€117,106+€6,097 (+5.5%) vs previous periodPrevious: €111,009
Profit (loss) for the financial year€93,520+€4,754 (+5.4%) vs previous periodPrevious: €88,766
Assets€653,857+€57,029 (+9.6%) vs previous periodPrevious: €596,828
Balance-sheet contextLatest financial period
Other operating income€52,816Previous: €56,960
Cash and bank€130,048Previous: €85,620
Retained earnings€543,296Previous: €497,378
Equity€639,316Previous: €588,644
Liabilities€14,541Previous: €8,184
Current assets€155,016Previous: €117,854
Current liabilities€10,058Previous: €8,184
Revenue trend2 periods
€237,469
2024-04-30
€255,487
2025-04-30
Operating profit (loss) trend2 periods
€111,009
2024-04-30
€117,106
2025-04-30
Profit (loss) for the financial year trend2 periods
€88,766
2024-04-30
€93,520
2025-04-30
Assets trend2 periods
€596,828
2024-04-30
€653,857
2025-04-30

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Declining
97.8 %2024-04-30: 98.6 %
Current ratioGood
100/100 · Improving
12.93x2024-04-30: 10.46x
Operating profit marginGood
100/100 · Improving
38.0 %2024-04-30: 37.7 %
Ratio history
Ratio2024-04-302025-04-30
Equity ratio98.6 %97.8 %
Current ratio10.46x12.93x
Operating profit margin37.7 %38.0 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID2512010-5
EU IDFIFPRO.2512010-5
MunicipalityKarleby
Current registered entries
2012-11-23Registered in Patent and Registration Office (Trade Register)
2012-11-29Registered in Tax Administration (Tax Administration)
2013-01-01Registered in Tax Administration (Prepayment Register)
2013-12-01Registered in Tax Administration (Employer Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A1
ExcellentCardioderma Oy
Grade unchangedA1 · new analysis 2026-10-17
Model score92/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Peer comparisonSame industry, size and age groupDescriptive comparison – does not change the model score.
70 peers
Solvency76%
Better than 76% of peers
Profitability61%
Better than 61% of peers
Liquidity80%
Better than 80% of peers
Revenue growth77%
Better than 77% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
4 observed filings
Latest registration lag147 days after period end
Typical registration lag148 days after period end
Annual continuity4 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note

No material separate warning signals.

Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A1
2026-10-1792/100 · v0.15
A1 → A1
A1
2026-09-17 12:0792/100 · v0.14
A3 → A1 · +17 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-04-30).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
A3
2026-09-1475/100 · v0.14
A3 → A3
A3
2026-09-1475/100 · v0.13
Oldest retained automatic assessment in this comparison
Automatic model gradeA1
Automatic model snapshot2026-10-17
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
94/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityVakiintunut
80/100

The company has about 13 years of registry continuity.

Registry and status signalsVakaa
76/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A1.
Financial statement availableFinancialEvidence verified
24 Sept 2026 · PRH / XBRLFinancial period ends 2026-04-30.
Risk grade updatedRisk gradeEvidence verified
17 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3 → A1.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.

Registry timeline

Trade register notifications shown on a timeline.

16 register eventsLatest event: 2025-09-25

Financial statements availability

Available financial statement periods and PRH source filings.

4 financial statement periodsLatest financial period: 2026-04-30

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2026-03-03.

This company profile has not been claimed yet

Cardioderma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.